Details for New Drug Application (NDA): 060770
✉ Email this page to a colleague
NDA 060770 describes OXYTETRACYCLINE HYDROCHLORIDE, which is a drug marketed by Hikma, Impax Labs, Proter, and Purepac Pharm, and is included in four NDAs. Additional details are available on the OXYTETRACYCLINE HYDROCHLORIDE profile page.
The generic ingredient in OXYTETRACYCLINE HYDROCHLORIDE is oxytetracycline hydrochloride. There are thirty-six drug master file entries for this compound. Additional details are available on the oxytetracycline hydrochloride profile page.
The generic ingredient in OXYTETRACYCLINE HYDROCHLORIDE is oxytetracycline hydrochloride. There are thirty-six drug master file entries for this compound. Additional details are available on the oxytetracycline hydrochloride profile page.
Summary for 060770
| Tradename: | OXYTETRACYCLINE HYDROCHLORIDE |
| Applicant: | Hikma |
| Ingredient: | oxytetracycline hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 250MG BASE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
